All In MedTech

Device Trial Radar · NCT07844681

Cyanoacrylate Skin Adhesive After Mohs Surgery or Wide Local Excision

A Prospective Randomized Study of Surgical Site Infection After Linear Repair With or Without Cyanoacrylate Skin Adhesive Following Mohs Micrographic Surgery and Wide Local Excision

Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingRandomized with 300 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

300

Planned (sponsor's estimate)

Start

Dec 1, 2026

Primary completion

Dec 30, 2028

Study completion Mar 30, 2029

Sponsor

Lead sponsor
University of MinnesotaAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 28, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Prevention
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will compare surgical site infection after linear repair with or without cyanoacrylate skin adhesive following Mohs micrographic surgery or wide local excision. Adult participants undergoing Mohs micrographic surgery or wide local excision for skin cancer with a surgical defect suitable for linear repair will be stratified by suture type and randomized to standardized running epidermal suture closure with or without cyanoacrylate skin adhesive. The primary outcome is surgical site infection within 30 days after surgery. Secondary outcomes include scar quality, treatment satisfaction, wound care burden, wound healing characteristics, antibiotic use, culture results, health care utilization related to wound concerns, and adverse events.

Conditions

  • Surgical Site Infection
  • Skin Cancer
  • Wound Healing

Interventions

  • Cyanoacrylate Skin AdhesiveDevice

    Cyanoacrylate skin adhesive will be applied in a thin, continuous layer along the repaired wound after hemostasis and epidermal closure are complete. The adhesive is an FDA-approved topical wound closure product used within its labeled indication.

  • Fast Gut Running Epidermal Suture ClosureProcedure

    Standardized running epidermal closure will be performed using fast gut absorbable suture material after Mohs micrographic surgery or wide local excision.

  • Vicryl Rapide Running Epidermal Suture ClosureProcedure

    Standardized running epidermal closure will be performed using Vicryl Rapide absorbable suture material after Mohs micrographic surgery or wide local excision.

  • Prolene Running Epidermal Suture ClosureProcedure

    Standardized running epidermal closure will be performed using Prolene non-absorbable suture material after Mohs micrographic surgery or wide local excision.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Surgical Site Infection Within 30 Days After Linear RepairTime frame: Within 30 days after Mohs micrographic surgery or wide local excision

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Oxboro Dermatology Clinic

    Minneapolis, Minnesota

  • University of Minnesota Dermatologic Surgery Clinic - CSC

    Minneapolis, Minnesota

  • University of Minnesota Dermatologic Surgery Clinic - MG

    Minneapolis, Minnesota

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.